Experiences on The Administration of Botulinum Toxin in Movement Disorders
- PMID: 33850802
- PMCID: PMC8016350
- DOI: 10.2478/jtim-2021-0003
Experiences on The Administration of Botulinum Toxin in Movement Disorders
Abstract
Background and objectives: Botulinum toxin injection has been used for many years for various indications such as cervical dystonia, blepharospasm, oromandibular dystonia, hemifacial spasm in neurology. Botulinum toxin injections have been made in our clinic for about ten years. We want to report our experiences about botulinum toxin treatment in neurologic disease.
Methods: In this study, the data of the patients receiving BoNT injection between January 2018 and December 2019 was retrospectively analyzed. Age, gender, botulinum toxin indications, and mean dose, duration of efficacy, side effects noted for each injection were recorded.
Results: There were 122 patients who received botulinum toxin injections between January 2018 and December 2019. Of the 122 patients identified, 28 had cervical dystonia, 61 had HFS, 21 had blepharospasm, 4 had generalized dystonia, 1 had hemidystonia following thalamic bleeding, 1 had tardive dystonia, 4 had migraine, 1 had bruxism and 1 had both migraine and bruxism.
Conclusion: BoNT injection is a treatment that has been used for various indications in neurology for almost 40 years. Side effects are limited and temporary with appropriate injections. We also had a wide range of indication profiles and high numbers of patients to whom we administered the BoNT treatment.
Keywords: botulinum toxin injections; indications; neurology.
© 2021 Buket Tuğan Yıldız, Deniz Tuncel Berktaş published by Sciendo.
Conflict of interest statement
Conflicts of Interest The authors declare that they have no conflict of interest.
Similar articles
-
[Botulinum toxin therapy for focal dystonia].Orv Hetil. 2009 Jul 19;150(29):1381-4. doi: 10.1556/OH.2009.28640. Orv Hetil. 2009. PMID: 19581172 Hungarian.
-
Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.Clin Exp Ophthalmol. 2014 Apr;42(3):254-61. doi: 10.1111/ceo.12165. Epub 2013 Aug 4. Clin Exp Ophthalmol. 2014. PMID: 23844601
-
Use of Alleviating Maneuvers for Periocular Facial Dystonias.JAMA Ophthalmol. 2016 Nov 1;134(11):1247-1252. doi: 10.1001/jamaophthalmol.2016.3277. JAMA Ophthalmol. 2016. PMID: 27606483
-
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.Toxicon. 2013 Jun 1;67:94-114. doi: 10.1016/j.toxicon.2012.12.004. Epub 2013 Feb 4. Toxicon. 2013. PMID: 23380701 Review.
-
Botulinum Toxin Treatment of Movement Disorders.Curr Treat Options Neurol. 2018 Feb 24;20(2):4. doi: 10.1007/s11940-018-0488-3. Curr Treat Options Neurol. 2018. PMID: 29478149 Review.
Cited by
-
Time to onset and duration of botulinum toxin efficacy in movement disorders.J Neurol. 2022 Jul;269(7):3706-3712. doi: 10.1007/s00415-022-10995-2. Epub 2022 Feb 3. J Neurol. 2022. PMID: 35113259 Free PMC article.
-
The role of microRNAs in ferroptosis.Front Mol Biosci. 2022 Oct 12;9:1003045. doi: 10.3389/fmolb.2022.1003045. eCollection 2022. Front Mol Biosci. 2022. PMID: 36310600 Free PMC article. Review.
References
-
- Matur Z, Parman Y. Botulinum toksininin nörolojide kullanım alanları. Klinik Gelişim. 2010;23:121–7.
-
- Türker H, Onar M, Demir O, Tunalı G. Ondokuz Mayıs Üniversitesi Nöroloji Kliniğinde Botulinum Toksin Uygulamaları: Retrospektif Bir Çalışma. O. M. Ü. Tıp Derg. 2007;24:6–14.
-
- Cardoso F, Jankovic J. Blepharospasm. Handbook of dystonia. Marcel Dekker. 1995:129–41.
-
- Çakmur R. Botulinum Toxin Treatment of Blepharospasm and Hemifacial Spasm. Arch Neuropsychiatry. 2010;47:6–10.
-
- Chaudhry N, Srivastava A, Joshi L. Hemifacial spasm: The past, present and future. J Neurol Sci. 2015;356:27–31. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources